MGC Pharmaceuticals to "keep chipping away" after first CannEpil delivery

Digital Asset Direct by MGC Pharmaceuticals Ltd

London, UK | June 02, 2023 10:17 AM Eastern Daylight Time

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Thomas Warner from Proactive after the Europe-based pharmaceutical company announced the delivery of the first doses of its CannEpil® units to patients in the United Kingdom. Clements also discusses recent changes at boardroom level and looks ahead to what investors can expect from MGC during the next few months, saying that the company will "keep chipping away."

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com